0 NASDAQ Companies - January 4, 2024Voyager Therapeutics Announces Pricing of Public OfferingLEXINGTON, Mass., Jan. 04, 2024 (GLOBE NEWSWIRE) — Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to advancing neurogenetic […]Read More
0 NASDAQ Companies - January 4, 2024Standard BioTools Stockholders Approve Merger with SomaLogicSOUTH SAN FRANCISCO, Calif., Jan. 04, 2024 (GLOBE NEWSWIRE) — Standard BioTools Inc. (Nasdaq: LAB), driven by a bold purpose […]Read More
0 NASDAQ Companies - January 4, 2024FormFactor Inc. To Present At The 26th Annual Needham Growth ConferenceLIVERMORE, Calif., Jan. 04, 2024 (GLOBE NEWSWIRE) — FormFactor, Inc. (Nasdaq: FORM) is pleased to announce its participation in the 26th […]Read More
0 NASDAQ Companies - January 4, 2024Texas Capital Bancshares, Inc. Announces Date for Full Year and Q4 2023 Operating ResultsDALLAS, Jan. 04, 2024 (GLOBE NEWSWIRE) — Texas Capital Bancshares, Inc. (NASDAQ: TCBI), the parent company of Texas Capital Bank, […]Read More
0 NASDAQ Companies - January 4, 2024Ekso Bionics Reports Certain Preliminary Fourth Quarter and Full Year 2023 Financial ResultsSAN RAFAEL, Calif., Jan. 04, 2024 (GLOBE NEWSWIRE) — Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader […]Read More
0 NASDAQ Companies - January 4, 2024Pacira Reports Preliminary Unaudited Fourth Quarter and Full-Year 2023 RevenuesTAMPA, Fla., Jan. 04, 2024 (GLOBE NEWSWIRE) — Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to […]Read More
0 NASDAQ Companies - January 4, 2024Axogen Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2023ALACHUA, Fla. and TAMPA, Fla., Jan. 04, 2024 (GLOBE NEWSWIRE) — Axogen, Inc. (NASDAQ: AXGN), a global leader in developing […]Read More
0 NASDAQ Companies - January 4, 2024Eledon Pharmaceuticals Highlights Recent Business Milestones and Provides 2024 OutlookReported updated data from ongoing Phase 1b trial in kidney transplantation demonstrating tegoprubart treatment successfully prevented kidney transplant rejection and […]Read More
0 NASDAQ Companies - January 4, 2024Axogen Announces Plan for Leadership Transition with CEO Karen Zaderej to Retire from Company by January 2025ALACHUA and TAMPA, Fla., Jan. 04, 2024 (GLOBE NEWSWIRE) — Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and […]Read More
0 NASDAQ Companies - January 4, 2024Axogen Announces Promotions on Research and Development TeamALACHUA, Fla. and TAMPA, Fla., Jan. 04, 2024 (GLOBE NEWSWIRE) — Axogen, Inc. (NASDAQ: AXGN), a global leader in developing […]Read More